Cancer

NHS England Expands At-home Cervical Cancer Screening

GE HealthCare Launches AI-Powered Breast Ultrasound

Astrin Biosciences Study Validates Blood Test For Early-Stage Breast Cancer Detection

Teal Health and UC Davis Health Launch At-Home Cervical Screening Study

FDA Approves Celcuity’s REVTORPYK for HR+/HER2-, PIK3CA Wild-Type Advanced Breast Cancer

Daye Research Makes the Case for Adding the Vaginal Microbiome to Cervical Cancer Risk Models

Roche’s Genentech Signs $490M Breast Cancer Drug Discovery Deal with Astex Pharmaceuticals

Imagion Biosystems Raises AU$3.75M; Extends Siemens Partnership to Advance Breast Cancer Trial

FDA Approves Pfizer’s IBRANCE for HR+/HER2+ Metastatic Breast Cancer

Quibim Launches AI Tool for Breast Cancer Detection via MRI in Europe and the UK

Color Health Adds At-Home HPV Self-Collection Kit to Virtual Cancer Clinic

Spotlight Medical Secures CE Mark for AI Breast Cancer Prognostic Test

OPTIMA Trial Finds Gene Test Can Identify Breast Cancer Patients Who Can Safely Forgo Chemotherapy

Aspira Women’s Health and Cleveland Clinic Expand Collaboration on AI-Powered Diagnostics for Ovarian Cancer and Endometriosis

FDA Approves ENHERTU for Early Breast Cancer in Two New Indications

Artera Receives FDA Clearance for AI-Powered Breast Cancer Risk Stratification Tool

FDA Approves VEPPANU, a New Class of Targeted Therapy for Advanced Breast Cancer

ScreenPoint Medical Raises $16M to Scale AI-Powered Breast Cancer Detection Globally

FDA Clears Waters’ At-Home HPV Self-Collection Kit for Cervical Cancer Screening

Sub-Q Bionics Raises $1.5M and Signs Mayo Clinic Licensing Deal to Develop Implantable Lymphedema Device

Australian Startup Proseek Bio Raises A$1.5M to Commercialize Ovarian Cancer Detection Blood Test

Previvor Edge Expands Platform to Deliver Personalized Cancer Risk Profiles in a Single Visit

Novartis Acquires Next-Generation Breast Cancer Drug in $3 Billion Deal

Manta Cares and Gilead Sciences Announce Collaboration to Support Patients Navigating Metastatic Breast and Lung Cancer